Your browser doesn't support javascript.
loading
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma.
Shirinbak, Soheila; Chan, Randall Y; Shahani, Shilpa; Muthugounder, Sakunthala; Kennedy, Rebekah; Hung, Long T; Fernandez, G Esteban; Hadjidaniel, Michael D; Moghimi, Babak; Sheard, Michael A; Epstein, Alan L; Fabbri, Muller; Shimada, Hiroyuki; Asgharzadeh, Shahab.
Afiliação
  • Shirinbak S; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
  • Chan RY; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
  • Shahani S; Department of Pediatrics, Los Angeles County + University of Southern California Medical Center, Los Angeles, CA, USA.
  • Muthugounder S; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Kennedy R; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Hung LT; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
  • Fernandez GE; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
  • Hadjidaniel MD; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
  • Moghimi B; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
  • Sheard MA; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
  • Epstein AL; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
  • Fabbri M; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Shimada H; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Asgharzadeh S; Department of Pediatrics, Children's Hospital Los Angeles and the Saban Research Institute, Los Angeles, CA, USA.
Oncoimmunology ; 10(1): 1838140, 2021 01 04.
Article em En | MEDLINE | ID: mdl-33489468
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Neuroblastoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Neuroblastoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article